EURO DEFI PADS ADULT; EURO DEFI PADS ADULT RADIOTRANSPARENT: EURO DEFI PADS PEDIATRIC
Device Facts
| Record ID | K103783 |
|---|---|
| Device Name | EURO DEFI PADS ADULT; EURO DEFI PADS ADULT RADIOTRANSPARENT: EURO DEFI PADS PEDIATRIC |
| Applicant | Fiab Spa |
| Product Code | LDD · Cardiovascular |
| Decision Date | Jun 16, 2011 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 870.5300 |
| Device Class | Class 2 |
| Attributes | Therapeutic, Pediatric |
Indications for Use
EURO DEFI PADS series of disposable multi-function electrodes are indicated for the following clinical applications: - external defibrillation - synchronized cardioversion - cardiac stimulation - ECG monitoring EURO DEFI PADS scries of disposable multi-function electrodes provide the conductive interface between the defibrillator and the patient's skin. These devices are available with different connectors compatible for use with different defibrillators. All devices are non-sterile and for single-use only. The pediatric model of EURO DEFI PADS disposable multi-function electrodes is intended for use on pediatric patient under eight years of age, or weighting less than 25 kg, the device is designed to deliver a maximum of 100 joule. The adult model of EURO DEFI PADS disposable multi-function electrodes is intended for use on adult patients and children older than eight years or greater than 25 kg, the device is designed to deliver a maximum of 360 joule. The radio-transparent adult model EURO DEFI PADS disposable multi-function electrodes for adult patient use only, is well suited for certain clinical applications involving radiographic viewing.
Device Story
Disposable multi-function electrodes; provide conductive interface between defibrillator and patient skin. Components: foam backing, laminated metallic substrate, conductive hydrogel, lead wires, molded connector. Used in hospitals and paramedic settings by medical staff. Facilitates delivery of electrical energy for defibrillation, cardioversion, or pacing; enables ECG signal acquisition. Passive device; no active processing. Benefits: enables life-saving cardiac therapy and monitoring. Single-use, non-sterile.
Clinical Evidence
Bench testing only. Biocompatibility testing per ISO 10993-5 (cytotoxicity) and ISO 10993-10 (irritation/hypersensitivity). Component compatibility testing (connector force, energy delivery, ECG monitoring). Electrical safety testing per ANSI/AAMI DF80:2003. Accelerated aging shelf-life testing (30 months).
Technological Characteristics
Foam backing, laminated metallic substrate, conductive hydrogel. Passive electrode interface. Radiopaque or radiotransparent versions. Single-use, non-sterile. Connectivity via molded connectors compatible with various defibrillator brands. Compliant with 21 CFR 898.12 and ANSI/AAMI DF80:2003.
Indications for Use
Indicated for external defibrillation, synchronized cardioversion, cardiac stimulation, and ECG monitoring. Pediatric model for patients <8 years or <25 kg (max 100J). Adult model for patients >8 years or >25 kg (max 360J). Radiotransparent model for adult use during radiographic imaging.
Regulatory Classification
Identification
Low-energy DC-defibrillator: A device that delivers into a 50 ohm test load an electrical shock of a maximum of 360 joules of energy used for defibrillating (restoring normal heart rhythm) the atria or ventricles of the heart or to terminate other cardiac arrhythmias. This generic type of device includes low energy defibrillators with a maximum electrical output of less than 360 joules of energy that are used in pediatric defibrillation or in cardiac surgery. The device may either synchronize the shock with the proper phase of the electrocardiogram or may operate asynchronously. The device delivers the electrical shock through paddles placed either directly across the heart or on the surface of the body. High-energy DC-defibrillator: A device that delivers into a 50 ohm test load an electrical shock of greater than 360 joules of energy used for defibrillating the atria or ventricles of the heart or to terminate other cardiac arrhythmias. The device may either synchronize the shock with the proper phase of the electrocardiogram or may operate asynchronously. The device delivers the electrical shock through paddles placed either directly across the heart or on the surface of the body.
Predicate Devices
- Adult Radiotranslucent Multi-function Electrodes (K080421)
- Adult Radiotransparent Multi-function Electrodes (K080421)
- Pediatric Radiotranslucent Multi-function Electrodes (K081442)
Submission Summary (Full Text)
{0}------------------------------------------------
Section 05
K103783 - Additional Information
Pad-type electrodes
## Submitter Information
FIAB SpA Via P. Costoli, 4 50039 Vicchio Florence - Italy
Phone: +39 055 8497916 Fax: +39 055 8497987 Contact person: Silvia Calabrò, Official Correspondent E-mail: regulatory@fiab.it
## Device name and classification
Trade name: EURO DEFI PADS series of disposable multi-function electrodes
Common name: defibrillation electrodes
Classification name: Electrode, Electrocardiograph, Multi-Function (21 CFR 870.2360, Product code MLN)
### Predicate device
Lawfully marked devices to which it is claimed equivalence:
| Trade name | 510(K) holder | 510(K) number |
|------------------------------------------------------|----------------|---------------|
| Adult Radiotranslucent Multi-function Electrodes | Heart Sync LLC | K080421 |
| Adult Radiotransparent Multi-function Electrodes | Heart Sync LLC | K080421 |
| Pediatric Radiotranslucent Multi-function Electrodes | Heart Sync LLC | K081442 |
### Device description
FIAB EURO DEFI PADS scries of disposable multi-function electrodes are made by a couple of pre-gelled self-adhesive pad-type clectrodes consisting of foam backing, laminated metallic substrate, conductive hydrogel, cabling and molded connector. The electrodes are passive devices providing the conductive interface between the defibrillator and the patient's skin. Each couple of electrodes is permanently attached with lead wires that join together in a safety connector suitable for direct connection to devices - both monophasic and biphasic of the main defibrillators brands nowadays present on the market.
The products are packaged in pairs inside water-vapor proof, heat scaled, non-transparent, aluminum/PE pouches.
FIAB EURO DEFI PADS scries of disposable multi-function clectrodes are available in the following versions: adult, adult radiotransparent, pediatric.
2011/05/10
1/4
FIAB spa – Via P. Costoli, 4 – 50039 VICCHIO – FLORENCE – ITALY ☏ +39 0558497999 - 晨 +39 0558497979 - www.fiab.it
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
{1}------------------------------------------------
Section 05
K103783 - Additional Information
Pad-type electrodes
All products are intended to be used by mcdical staff only in not-sterile environment. All disposable devices are not-sterile and for single patient use only.
## Intended use
EURO DEFI PADS series of disposable multi-function electrodes are indicated for the following clinical applications:
- external defibrillation -
- synchronized cardioversion +
- cardiac stimulation
- ﺳ ECG monitoring
EURO DEFI PADS scries of disposable multi-function electrodes provide the conductive interface between the defibrillator and the patient's skin.
These devices are available with different connectors compatible for use with different defibrillators. All devices are non-sterile and for single-use only.
The pediatric model of EURO DEFI PADS disposable multi-function electrodes is intended for use on pediatric patient under eight years of age, or weighting less than 25 kg, the device is designed to deliver a maximum of 100 joule.
The adult model of EURO DEFI PADS disposable multi-function electrodes is intended for use on adult patients and children older than eight years or greater than 25 kg, the device is designed to deliver a maximum of 360 joule.
The radio-transparcnt adult model EURO DEFI PADS disposable multi-function electrodes for adult patient use only, is well suited for certain clinical applications involving radiographic viewing.
## Comparison to predicate
Safety and effectiveness of adult version:
| COMPARISON | HEART SYNC Adult Radiotranslucent | FIAB EURO DEFI PADS |
|---------------------------------|----------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|
| AREAS | Electrodes (K080421) | Adult Electrodes |
| Indication for | For use as disposable electrodes on<br>external defibrillators for monitoring,<br>pacing, cardioversion and defibrillation | SAME |
| use | | |
| Where used | Hospitals and paramedic situation | SAME |
| Basic features | Radiotranslucent, non sterile, latex free,<br>single use, self adhesive, in sealed foil<br>pouch | Radiopaque, non sterile, latex<br>free, single use, self adhesive,<br>in sealed foil pouch |
| Target<br>population | Adult patients | SAME |
| Energy used<br>and/or delivered | For use on defibrillators whose output is<br>classified as low power (360 joule<br>maximum) | SAME |
| Standard met | 21 CFR 898.12 performance standard;<br>ANSI/AAMI DF80:2003 standard | SAME |
| 2011/05/10 | | 2/4 |
FIAB spa - Via P. Costoli, 4 - 50039 VICCHIO - FLORENCE - ITALY ☏ +39 0558497999 - 룸 +39 0558497979 - www.fiab.it
{2}------------------------------------------------
Section 05
K103783 - Additional Information
Pad-type electrodes
Safety and effectiveness of adult radiotransparent version:
| COMPARISON<br>AREAS | HEART SYNC Adult<br>Radiotransparent Electrodes<br>(K080421) | FIAB EURO DEFI PADS<br>Adult Radiotransparent<br>Electrodes |
|---------------------------------|----------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------|
| Indication for<br>use | For use as disposable electrodes on<br>external defibrillators for monitoring,<br>pacing, cardioversion and defibrillation | SAME |
| Where used | Hospitals and paramedic situation | SAME |
| Basic features | Radiotransparent, non sterile, latex free,<br>single use, self adhesive, in sealed foil<br>pouch | Radiotransparent except for wire-<br>pad connection, non sterile, latex<br>free, single use, self adhesive, in<br>sealed foil pouch |
| Target<br>population | Adult patients | SAME |
| Energy used<br>and/or delivered | For use on defibrillators whose output is<br>classified as low power (360 joule<br>maximum) | SAME |
| Standard met | 21 CFR 898.12 performance standard;<br>ANSI/AAMI DF80:2003 standard | SAME |
Safety and effectiveness of pediatric version:
| COMPARISON<br>AREAS | HEART SYNC Pediatric<br>Radiotranslucent Electrodes (K081442) | FIAB EURO DEFI PADS<br>Pediatric Electrodes |
|---------------------------------|----------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|
| Indication for<br>use | For use as disposable electrodes on<br>external defibrillators for monitoring,<br>pacing, cardioversion and defibrillation | SAME |
| Where used | Hospitals and paramedic situation | SAME |
| Basic features | Radiotranslucent, non sterile, latex free,<br>single use, self adhesive, in sealed foil<br>pouch | Radiopaque, non sterile, latex<br>free, single use, self adhesive,<br>in sealed foil pouch |
| Target<br>population | Pediatric patients whose weight is less than<br>25 kg | SAME |
| Energy used<br>and/or delivered | Do not exceed a settings of 100 joules<br>while defibrillating | SAME |
| Standard met | 21 CFR 898.12 performance standard;<br>ANSI/AAMI DF80:2003 standard | SAME |
The products covered by this submission are substantially equivalent to other disposable multi-function electrodes, that are legally marked for this purpose. Specifically FIAB EURO DEFI PADS series of disposable multi-function electrodes are substantially equivalent to HEART SYNC clectrodes.
2011/05/10
.
3/4
FIAB spa - Via P. Costoli, 4 - 50039 VICCHIO - FLORENCE - ITALY ☏ +39 0558497999 - 易 +39 0558497979 - www.fiab.it
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
{3}------------------------------------------------
Section 05
K 103783 - Additional Information
Pad-type electrodes
FIAB EURO DEFI PAD clectrodes have the same intended use as the predicate device. There are no technical differences in the design, materials, packaging, and labeling compared to the predicate. The defibrillation pads meet the standards referenced above. They are produced and tested according to all requirements to guarantee safety and effectiveness (as shown in section 17 and 18 of the submission). According to the riskbenefit analysis (ISO 14971 standards), the risk has been decemed acceptable. The performance is expected to be the same as the predicate device (see section 12 of the submission). In addition to the descriptive characteristics the following tests were performed to establish substantial equivalence:
Biocompatibility - Biocompatibility testing of all patient contacting material was performed according to ISO10993-5 for cytotoxicity and 10993-10 for irritation and delayed-type hypersensitivity. The results were reported as passing by the NAMSA organization and are congruent with the predicate device.
Component Compatibility - Compatibility testing was conducted to ensure interoperability between the FIAB Euro Defi Pads and the listed defibrillators, pacers, and monitors. This included testing of the insertion and extraction forces of the physical connectors, amount of energy delivered through the pads, and the monitoring of a simulated heartbeat
Electrical Standards - Testing was conducted to mect AAMI/ANSI standard DF80:2003. The FIAB Euro Defi Pads passed the tests related to defibrillation pads
Shelf-Life Testing - Accolerated age testing was conducted to assure a shelf life of 30 months.
2011/05/10
4/4
FIAB spa - Via P. Costoli, 4 - 50039 VICCHIO - FLORENCE - ITALY 密 +39 0558497999 - 屎 +39 0558497979 - www.fiab.it
{4}------------------------------------------------
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of three human figures, represented by flowing lines, suggesting a sense of unity and support.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
FIAB SpA c/o Mr. Francesco Batistini Counsellor of the Board Via Costoli, 4 50039 Vicchio Florence - Italy
JUN 1 6 291
Re: K103783
Trade Name: FIAB Euro Defi Pads Regulation Number: 21 CFR 870.5300 Regulation Name: DC-Defibrillator Regulatory Class: Class II (two) Product Code: LDD Dated: May 10, 2011 Received: May 13, 2011
Dear Mr. Batistini:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{5}------------------------------------------------
Page 2 -- Mr. Francesco Batistini
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely vours.
W.g. Hellebaum
- Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{6}------------------------------------------------
# Indications For Use Statement K103783 - Additional Information
Section 04
I. Life, Liberty, Happiness
Pad-type clectrodes
Indications for Use
510(K) Number: K103783
Device Name: EURO DEFI PADS series of disposable multi-function electrodes
Indications For Use:
EURO DEFI PADS series of disposable multi-function electrodes are indicated for the following clinical applications:
- external defibrillation -
- synchronized cardioversion
- cardiac stimulation
- ECG monitoring -
EURO DEFI PADS scries of disposable multi-function electrodes provide the conductive interface between the defibrillator and the patient's skin. These devices are available with different connectors compatible for use with different defibrillators. All devices are non-sterile and for single-use only.
The pediatric model of EURO DEFI PADS disposable multi-function electrodes is intended for use on pediatric patient under eight years of age, or weighting less than 25 kg, the device is designed to deliver a maximum of 100 joule.
The adult model of EURO DEFI PADS disposable multi-function electrodes is intended for use on adult patients and children older than eight years or greater than 25 kg, the device is designed to deliver a maximum of 360 joule.
The radio-transparent adult model EURO DEFI PADS disposable multi-function electrodes for adult patient use only, is well suited for certain clinical applications involving radiographic viewing.
______________________________________________________________________________________________________________________________________________________________________________ Prescription Use AND /OR (Part 21 CFR 801 Subpart D)
Over-the-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
W. A. Kilbourne
(Division Sign-Off)
Division of Cardiovascular Devices
K103783 510(k) Number
2011/05/10
1 / 1
FIAB spa - Via P. Costoli, 4 - 50039 VICCHIO - FLORENCE - ITALY 密 +39 0558497999 - 黒 +39 0558497979 - www.fiab.it
